Education
About Us
Working with TipRanks
Follow Us
Precigen (PGEN)
NASDAQ:PGEN
Earnings Data
Report Date
Mar 09, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.08Last Year’s EPS
-0.07Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call was optimistic, highlighting the transformative approval and rapid deployment of Papcemias, along with strong financial positioning and manufacturing capabilities. Despite increased expenses, the company anticipates reaching cash flow breakeven by 2026.Company Guidance
FDA Approval of Papcemias
Papcemias received full FDA approval with a broad label for all adult RRP patients, marking it as the first and only treatment available for recurrent respiratory papillomatosis (RRP).
Papcemias Clinical Efficacy
51% of patients achieved complete response with no surgery required for twelve months post-treatment, and 86% had a reduction in surgical burden after treatment with Papcemias.
Rapid Commercial Deployment
The sales team was fully deployed, engaging 90% of target institutions quickly, and payer coverage advancing rapidly with over 80 million lives covered.
Strong Financial Position
Precigen expects its cash, investments, and projected revenues from Papcemias to fund operations to cash breakeven by 2026.
Manufacturing Capacity
Precigen has a dedicated in-house cGMP facility fully operational and successfully inspected by the FDA for Papcemias drug substance manufacturing.
PGEN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PGEN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | $3.86 | $4.85 | +25.65% |
Aug 12, 2025 | $1.74 | $1.80 | +3.45% |
May 14, 2025 | $1.28 | $1.31 | +2.34% |
Mar 19, 2025 | $1.79 | $1.80 | +0.56% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Precigen (PGEN) report earnings?
Precigen (PGEN) is schdueled to report earning on Mar 09, 2026, After Close (Confirmed).
What is Precigen (PGEN) earnings time?
Precigen (PGEN) earnings time is at Mar 09, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PGEN EPS forecast?
PGEN EPS forecast for the fiscal quarter 2025 (Q4) is -0.08.